Search Results 581-590 of 25612 for treatment resistant depression

1. A Study for Women who have Platinum Resistant Ovarian Cancer to Evaluate EC145 Combined with Pegylated Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone - Mayo Clinic

   The purpose of this study is to compare the progression-free survival in women who have platinum-resistant ovarian cancer, who receive combination therapy with ...

2. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... treating patients with treatment resistant chronic lymphocytic leukemia or small lymphocytic lymphoma. Akt inhibitor MK2206 may stop the growth of cancer ...

3. A Study of Anxiety and Depression Influence Voiding Outcomes after Pelvic Surgery - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

4. Behcet's disease - Diagnosis and treatment - Mayo Clinic

   ... treating some of the signs and symptoms of Behcet's, especially for people who have more-severe or resistant symptoms. Examples include infliximab (Remicade) ...

5. A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE) - Mayo Clinic

   severe, refractory SLE, IIM, and SSc. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

6. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer · More about research ...

7. CAR-T Cell Therapy Program - Department home - Mayo Clinic

   CAR -T cell therapy may be a treatment option for: Relapsed, refractory B-cell acute lymphoblastic leukemia; Relapsed, refractory B-cell non-Hodgkin's lymphoma ...

8. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

   Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia. Print details. Share; Facebook · Twitter.

9. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma · More about research at Mayo Clinic.

10. Mayo Clinic Radio: Pancreatic Cancer/Postpartum Depression/Population Health Management

    Pancreatic cancer remains a challenge to treat, but newer combination therapies are modestly improving survival rates. Cancer surgeon Dr. Mark Truty discusses ...